Intravenous Immunoglobulin Market Trends Global Industry Analysis, Size, Top Manufacturers, Share, Growth, Opportunities & Forecast to 2026
Market Study Report LLC has a newly added “Global Intravenous Immunoglobulin Market Report” that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, and forecast in the coming years.
Delaware, Selbyville – June 14, 2019 /MarketersMedia/ —
The global Intravenous Immunoglobulin Market majorly is driven by rising elderly population, increasing occurrence of immunodeficiency disorders, growing implementation of IVIG procedures and increasing usage of off-label indications. Increasing number of patients with immunodeficiency disease is the primary reason for the expansion of IVIG procedures. According to the World Health Organization (WHO), there are approximately 50 diverse Primary Immune Deficiency (PID) such as X-lined hypo-gamma-globulinemia, specific antibody deficiency and others.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1695093/
The Global Intravenous Immunoglobulin Market Size is anticipated to reach over USD 16,882.15 Million by 2026, according to a new research report. Immunoglobulins (IGs) are glycoproteins that are formed in the blood plasma in response to the antigens (Ag), which are considered as a foreign material to the host system. IGs are highly composite objects and precise in their nature. They are achieved from blood by fractionation procedure and filtered fo non-therapeutic as well as therapeutic applications. In therapeutics, they are administered intravenously for the treatment of several immunodeficiency.
The U.S. National Library of Medicine and National Institute of Health, around 6 million patients are suffering from PID globally. Rising occurrences of these immune diseases is anticipated to bolster the demand for intravenous immunoglobulin treatments during the forecast period. The demand for IVIG treatments for the primary and acquired immunodeficiency disorder is growing as it is the only available as well as most effective treatment option. Moreover, inactive lifestyle behaviors, including intake of saturated fats, sugars and salts, less physical actions, and high alcohol intake have led to the surge in the occurrence of such diseases. Increasing occurrence of such lifestyle related disease including antibody deficiency disorders and obesity are the factors anticipated to drive the global intravenous immunoglobulin market growth.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1695093/
The global Intravenous Immunoglobulin Market is segmented on the basis of Application and geography. On the basis of application, the global Intravenous Immunoglobulin Market is categorized into Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Multifocal motor neuropathy, Myasthenia Gravis, Chronic Lymphocytic Leukemia, Kawasaki disease, Guillain-Barre syndrome, and Idiopathic Thrombocytopenic Purpura (ITP). In 2017, Hypogammaglobulinemia is estimated to dominate the application segment.
The dominancy is attributed to the growing global occurrences of primary immunodeficiency diseases (PID). It is the most common chronic immune defect in patients with lymphoproliferative disorders (LPDs). According to the Centers for Disease Control and Prevention (CDC) in 2012, the global occurrence rate of hypogammaglobulinemia was around 2 per 100,000 populations moreover, the number of people suffering this type of disease are estimated to increase during the forecast period. Growing occurrence of immunodeficiency disorders associated with the high implementation of IVIG therapies is expected to drive the segment growth significantly.
Some major key players in global Intravenous Immunoglobulin Market include Baxter International Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc., and Bayer Healthcare among others.
Table of Content:
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Intravenous Immunoglobulin Market Insights
3.1. Intravenous Immunoglobulin Industry snapshot
3.2. Intravenous Immunoglobulin – Ecosystem analysis
3.3. Intravenous Immunoglobulin Market dynamics
3.3.1. Intravenous Immunoglobulin Market Forces
184.108.40.206. Intravenous Immunoglobulin Market driver analysis
220.127.116.11. Intravenous Immunoglobulin Market restraint/challenges analysis
18.104.22.168. Intravenous Immunoglobulin Market opportunity analysis
3.4. Industry analysis – Porter’s five force
3.4.1. Bargaining power of supplier
3.4.2. Bargaining power of buyer
3.4.3. Threat of substitute
3.4.4. Threat of new entrant
3.4.5. Degree of competition
3.5. Intravenous Immunoglobulin Market PEST analysis, 2017
3.5.1. Intravenous Immunoglobulin Industry trends
3.5.2. Competitive Ranking Analysis
4. Intravenous Immunoglobulin Market Size and Forecast by Application
5. Intravenous Immunoglobulin Market Size and Forecast by Regions
6. Intravenous Immunoglobulin Market Company Profiles
For more information on this report at: https://bit.ly/2wSquul
Intravenous Immunoglobulin Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
Intravenous Immunoglobulin Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Intravenous Immunoglobulin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Intravenous Immunoglobulin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Intravenous Immunoglobulin market covering all important parameters.
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Release ID: 524694